Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Scil Proteins GmbH / Navigo Proteins
Scil Proteins GmbH / Navigo Proteins
Activities:
Manufacturing
Ingredients
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Media
UV-Cap acquires 100% shares of Scil Proteins
Scil Proteins is acquired from Bionet Ventures and renamed Navigo Proteins
Research & Development
ITM and Scil Proteins agree targeted radio conjugates partnership
German firms will develop targeted radio conjugates for imaging and therapy purposes, in a variety of indications
Manufacturing
Wacker acquires Scil Proteins Production
The transaction will create a leading microbial-based biopharmaceutical manufacturer
Ingredients
Scil Proteins receives EMA approval for commercial production of Reteplase
The recombinant protein will be produced in Halle, Germany
Research & Development
Rainer-Rudolph-Foundation acknowledges outstanding research
Awards three prizes to young researchers in the fields of protein biochemistry and biotechnology
Ingredients
Scil Proteins establishes business development organisation in California
To be headed by Garry Merry
Pharmaceutical
Call for entries to Rainer Rudolph Foundation prizes
Closing date is 31 March
Subscribe now